VLVladimir G. Lubyansky

Vladimir G. Lubyansky

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vladimir G. Lubyansky has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Risk factors of high amputations in purulent-destructive forms of diabetic foot and prospects for surgical treatment

    by A.N. Zharikov, V.G. Lubyansky, A.R. Aliev

    Objective. To analyze the risk factors of high amputations in purulent-destructive forms of diabetic foot and evaluate the effectiveness of complex surgical treatment. Material and methods. In 2020—2024, we analyzed treatment outcomes in 101 patients with purulent-destructive forms of diabetic infected foot syndrome. Of these, 64 (63.4%) ones had neuropathic form, 37 (36.6%) — neuroischemic form of disease. The factors leading to high amputations in patients with diabetes mellitus were studied, and a comprehensive program for optimizing surgical treatment was developed. Results. Phlegmon of the feet, shins and purulent wounds after previous drainage predominated (n=41, 64%) among patients with neuropathic form. Neuroischemic form was predominantly characterized by multiple-level atherosclerotic lesions of arteries under purulent process or gangrene of fingers (62%). Drainage of foot and lower leg phlegmons dominated among patients with neuropathic forms (55%), in the group of neuroischemic form — minor amputations (toes, foot) and necrectomy (78%). Various revascularization procedures for critical limb ischemia were performed in 82% of cases. Along with the main surgical measures, various methods of local wound treatment were used. Correction of complications was carried out by various specialists taking into account individual course of disease. Conclusion. An integrated approach with early and wide drainage of lower limb phlegmons in patients with diabetes mellitus, vascular technologies for correction of ischemia and effective local treatment using vacuum therapy, physiotherapy, hyperbaric oxygenation decreased «large» anatomical losses associated with high amputations. Amputation of the lower leg and thigh was performed in 4 (4%) and 3 (3%) cases, respectively (6.9%).

  • Open Access

    AN IMPROVED METHOD OF ENDOSCOPIC INJECTION HEMOSTASIS IN PEPTIC GASTRODUODENAL BLEEDING

    by K.K. Zhussupov, N.B. Omarov, V.G. Lubyansky, N.M. Zhumazhanov, Ye.K. Kairkhanov, O.G. Tashtemirova, R.S. Kazangapov, S.S. Imangazinova, Ye.D. Mamyrov

    Introduction. Peptic gastroduodenal bleeding is one of the leading causes of non-variceal upper gastrointestinal bleeding and is associated with a high risk of rebleeding and mortality. Despite advances in endoscopic technologies, the effectiveness of standard injection hemostasis methods remains limited, necessitating further improvement of therapeutic approaches. Aim. To improve the effectiveness of endoscopic treatment of peptic gastroduodenal bleeding through the development and clinical evaluation of an improved endoscopic injection-application hemostasis technique. Materials and Methods. A controlled clinical study was conducted involving 60 patients with peptic gastroduodenal bleeding. Patients were divided into a main group (n = 31), in which the developed improved endoscopic injection-application hemostasis method using an additional manipulation channel was applied, and a control group (n = 29), which received standard endoscopic treatment. The effectiveness of primary hemostasis, the incidence of rebleeding, the dynamics of endoscopic changes according to the Forrest classification, ulcer healing rates, laboratory parameters, and length of hospital stay were evaluated. Results. The use of the improved method achieved primary hemostasis in 96.8% of patients and significantly reduced the rate of early rebleeding to 3.2% compared with 13.8% in the control group (p < 0.05). The main group demonstrated faster ulcer epithelialization, earlier stabilization of the endoscopic findings, and a reduction in hospital stay by an average of 3.1 days. No complications or adverse effects were observed. Conclusions. The improved endoscopic injection-application hemostasis method is an effective and safe approach for the treatment of peptic gastroduodenal bleeding, providing a reduction in rebleeding rates, acceleration of reparative processes, and shortening of hospital stay. The method may be recommended for clinical practice, particularly in patients at high risk of recurrent bleeding. Введение. Язвенные гастродуоденальные кровотечения являются одной из основных причин неварикозных кровотечений из верхних отделов желудочно-кишечного тракта и сопровождаются значительным риском рецидивов и летальности. Несмотря на развитие эндоскопических технологий, эффективность стандартных инъекционных методов гемостаза остаётся ограниченной, что требует дальнейшего совершенствования методов лечения. Цель. Повысить эффективность эндоскопического лечения язвенных гастродуоденальных кровотечений путём разработки и клинической оценки эффективности усовершенствованного способа эндоскопического инъекционно-аппликационного гемостаза. Материалы и методы. Проведено контролируемое клиническое исследование с участием 60 пациентов с язвенными гастродуоденальными кровотечениями. Пациенты были распределены на основную группу (n = 31), в которой применялся разработанный усовершенствованный метод эндоскопического инъекционно-аппликационного гемостаза с использованием дополнительного манипуляционного канала, и контрольную группу (n = 29), получавшую стандартное эндоскопическое лечение. Оценивались эффективность первичного гемостаза, частота рецидивов кровотечения, динамика эндоскопических изменений по классификации Forrest, темпы репарации язвенного дефекта, лабораторные показатели и продолжительность госпитализации. Результаты. Применение усовершенствованного метода позволило достичь первичного гемостаза у 96,8% пациентов и достоверно снизить частоту ранних рецидивов кровотечения до 3,2% по сравнению с 13,8% в контрольной группе (p < 0,05). В основной группе отмечены более быстрые темпы эпителизации язвенного дефекта, ранняя стабилизация эндоскопической картины и сокращение сроков стационарного лечения в среднем на 3,1 суток. Осложнений и побочных эффектов не зарегистрировано. Выводы. Усовершенствованный эндоскопический инъекционно-аппликационный способ гемостаза является эффективным и безопасным методом лечения язвенных гастродуоденальных кровотечений, обеспечивающим снижение частоты рецидивов, ускорение репаративных процессов и сокращение сроков госпитализации. Метод может быть рекомендован для внедрения в...

  • Open Access

    ALGORITHMS FOR SURGICAL TREATMENT OF POSTOPERATIVE COMPLICATIONS IN ABDOMINAL SURGERY

    by Andrey N. Zharikov, Vladimir G. Lubyansky, Alexander R. Aliev, Vasily V. Seroshtanov, Oleg A. Peleganchuk

    Introduction. Modern abdominal surgery is expanding its scope due to the increasing number and complexity of surgical procedures. At the same time, the incidence of postoperative abdominal complications (PACs) is also rising, and their diagnosis in district hospitals and interdistrict departments is difficult due to the vagueness of the clinical picture. This underscores the need to develop algorithms for rational surgical tactics at the specialized treatment stage. Objective. To analyze the causes of PAC in patients undergoing primary surgery in cities and districts of the Altai Krai and to develop diagnostic and treatment algorithms at the specialized care stage. Materials and Methods. A retrospective analysis of the medical records of 125 deceased patients with PAC admitted to the 3rd stage of surgical care from 2021 to 2025 was performed. The leading nosologies among the causes of death were found to be: acute pancreatitis (29,6%), colon cancer (13,6%), acute adhesive intestinal obstruction (10,4%), and strangulated hernia (10%). The immediate causes of death were postoperative peritonitis, intestinal perforations, anastomotic leakage, and acute kidney injury. Three streams of patients with PAC were identified: 1. Disseminated process (peritonitis, acute intestinal perforations, anastomotic leakage). 2. Limited purulent-inflammatory process (abscesses, intestinal fistulas, postnecrotic cysts). 3. Non-inflammatory process (early adhesive postoperative intestinal obstruction, hemoperitoneum). Three surgical treatment algorithms were developed depending on the resulting flow patterns. Results. In patients in the first group, the active surgical approach included programmed abdominal debridement, obstructive bowel resections with delayed anastomoses or enterostomies. During debridement, an open-abdomen approach was used with Bogota bags, vacuum aspiration, and negative pressure. The surgical approach in patients in the second group included transabdominal or transgastric drainage of localized purulent collections using ultrasound (US) and EUS, as well as a mini-access. Treatment of non-formed intestinal fistulas was performed using obturation and continuous aspiration. In patients with early adhesive postoperative intestinal obstruction, conservative treatment was effective in 70% of cases. Surgical treatment presented technical challenges due to the extensive nature of the adhesions. In these cases, total adhesiolysis was not always used to avoid injury to the intestinal loops, and the surgery was completed with a jejunotransverse anastomosis. Conclusion. Surgical treatment of patients with PAС presents significant challenges. The previous operation and the severity of the patient's condition distort the clinical picture and do not always allow for a timely postoperative diagnosis. Early referral of such patients to a specialized surgical treatment center is essential, with three patient streams established depending on the extent of the purulent process and the implementation of modern, innovative treatment methods in each stream.

  • Open Access

    Application of an original fibrin coating in prosthetic hernioplasty in patients with postoperative ventral hernias

    by V. G. Lubyansky, V. V. Seroshtanov, S. V. Leontyev, D. M. Shtyrov, S. A. Podkovyrov, С. B. Леонтьев

    Background. The number of patients with large postoperative ventral hernias does not tend to decrease. Recurrent hernias after prosthetic hernioplasty occur in 5–25 %. In 1–10 % of patients, the implant becomes infected with the formation of fistulas.The aim. To develop and apply an original fibrin coating of the implant to accelerate the processes of fibrosis and fixation of the implant in the tissues in large postoperative ventral hernias.Material and methods. Experimental studies were carried out on laboratory animals and bench experiments aimed at developing a fibrin composite for coating mesh implants. Examined and operated on using the technology described by V.I. Belokonev. Eighty patients with large postoperative ventral hernias. Among them there were 37 (46.3 %) men and 43 (53.7 %) women. The patients were examined using standard laboratory and instrumental studies.All patients were divided into 2 groups, comparable by gender, age and size of the hernia defect. Group 1 included patients who underwent only V.I. surgery. Belokoneva. The second group was represented by 30 (37.5 %) patients, where after hernia repair and repair of the aponeurosis defect, a fibrin composite was applied to the mesh implant.Results. The formation of fibrous tissue and the absence of a pronounced inflammatory reaction in the area of application of the fibrin composite within the abdominal wall were detected. In a clinical study, it was found that in group 1 without implant coverage, infiltrates in the area of the postoperative suture occurred in 5 patients (6.3 %). Small fluid accumulations in 3 (3.8 %) patients.Conclusion. After using fibrin coating to treat implants, the number of fluid accumulations and infiltrates was lower compared to the main group. No relapses were found in the long-term period up to 1 year.


  • Combined surgical treatment of patients with ulcerative gastroduodenal bleeding

    by A.N. Zharikov, V.G. Lubyansky, A.R. Aliev, S.A. Dorokhina, Barnaul Regional Clinical Emergency Hospital, V.M. Karkavin, Yu.V. Zhelezkov

  • EXPERIMENTAL STUDY OF THE APPLICATION OF THE ORIGINAL FIBRIN COMPOSITE IN SURGICAL TREATMENT OF PATIENTS WITH LARGE POSTOPERATIVE HERNIAS

    by Altai State Medical University, Vladimir G. Lubyansky, Vasily V. Seroshtanov, Andrei N. Zharikov, Sergey V. Leontiev, Altai Krai Regional Clinical Hospital, Nikolay I. Shipilov

    Introduction. The increase in the number of abdominal surgeries with laparostomy formation in recent years has been accompanied by an increase in the number of postoperative ventral hernias. Mortality in this category of patients ranges from 0.1 to 2.9% for planned surgeries and from 10 to 26% for strangulated hernias. One of the reasons is implant suppuration in the postoperative wound with subsequent septic complications and increasing antibiotic resistance of pathogenic microorganisms. Objective. To experimentally study the effectiveness of using the original fibrin composite to improve the adaptation of the mesh implant in the tissues of the anterior abdominal wall in the treatment of postoperative ventral hernias. Material and methods. The experimental in vitro study included studying the process and mechanisms of fibrin clot formation when various components to human plasma cryoprecipitate. The second stage of the study was to study the effect of surgical trauma and the introduced components of the fibrin composite on the formation of fibrous tissue. In a bacteriological laboratory, the risk of infection of a mesh implant treated with cryoprecipitate and its effect on E growth. Coli, St. Aureus, and P. Aureginosa colonies were studied. In the clinic, 60 patients with large postoperative ventral hernias were operated on, including 39 women and 21 men. In the main group, 30 patients underwent herniotomy and implant installation, and the original fibrin composite was applied. In the comparison group, 30 patients underwent a herniotomy in a modification of the Belokonev operation. The average age of the patients in both groups was 63±2.8 years. Results. When thrombin is added to the cryoprecipitate in in vitro experiments, a dense clot is formed which in the early stages is well modeled on a polypropylene mesh, subsequently forming a fibrin coating. The fibrin composite has a bacteriostatic effect, which helps to prevent infection and suppuration of the implant in the future. In the patients operated in the main group, the immediate postoperative period was without complications. In the comparison group, a long period of leukocytosis was observed in the postoperative period. Conclusions. The original fibrin composite has a bacteriostatic effect and prevents active microflora growth of microflora in the postoperative wound. The original fibrin composite covers the mesh implant, promoting rapid fibrous tissue. The use of this technology in the clinic is available in surgical practice and is not accompanied by the occurrence of complications.

  • Open Access

    Experience in surgical treatment of enteroatmospheric fistulas in the late period of postoperative peritonitis

    by A. N. Zharikov, V. G. Lubyanskiy, A. R. Aliev, V. V. Seroshtanov, K. E. Vlasov

    Background. Enteroatmospheric fistulas (EAF) that occur during the use of the “open abdomen” surgical tactics are a complex surgical pathology with a high mortality rate.The aim. To assess the effectiveness of treatment of various forms of enteroatmospheric fistulas in patients with postoperative peritonitis using vacuum aspiration technology.Methods. We assessed the results of the surgical treatment of 46 patients with EAF in the late course of postoperative peritonitis (PP). Three clinical and morphological groups were distinguished: group 1 (n = 24) – EAF in small wounds of the anterior abdominal wall; group 2 (n = 15) – EAF opening into limited cavities; group 3 (n = 7) – EAF opening into laparostoma wounds. In group 1, a fistula was formed using continuous aspiration devices or VAC systems. In group 2, we used continuous aspiration of intestinal contents from the cavity. In group 3, laparostoma was treated using vacuum devices with isolation of the intestinal fistula and simulation of a floating enterostoma.Results. Group 3 of patients with EAF was characterized by a high flow rate (1224.2 ± 210.3 ml), duration of treatment (87.3 ± 12.5 day), extensive laparostoma (335.4 ± 14.3 сm2), high mortality rate (57.1 %). The best results of treatment were obtained in groups 1 and 2. The flow rate was 675.8 ± 154.3 and 541.3 ± 114.1 ml, the duration of treatment was 2 or 3 times less (37.7 ± 6.1 and 26.4 ± 5.2 days), the mortality rate was 8.3 % and 6.7 % respectively.Conclusion. EAF that occur when using the “open abdomen” surgical tactics due to the impossibility of their isolation in extensive wounds of the anterior abdominal wall are complicated clinical and morphological forms. For their treatment, it is advisable to use VAC systems, aimed at the treatment of both the anterior abdominal wall wound itself and the intestinal fistula opening into it for its gradual extraterritorialization by modeling a floating enterostoma in a vacuum device.

  • Open Access

    STAGED SURGICAL TREATMENT OF PORTAL AND INFERIOR VENA CAVA THROMBOSIS WITH SEGMENTAL NECROSIS OF THE SMALL INTESTINE: A CASE REPORT

    by Андрей Николаевич Жариков, Vladimir G. Lubyansky, Александр Руштиевич Алиев

    Acute venous mesenteric thrombosis can be combined with thrombosis of the inferior vena cava, portal vein, or be their result. In this situation, small bowel ischemia manifests itself as segmental necrosis, with the appearance of new foci of necrosis in time. Diagnostics of the prevalence of venous thrombosis and attack control surgery in the background of anticoagulant therapy, described in clinical observation, allowed the determination of the level of damage to the inferior vena cava, control the formation of new necrosis of the intestinal wall, improve blood supply to the remaining parts of the intestine after double resection, and perform delayed distal anastomosis of the proximal small intestine with ileostomy under conditions of confirmed adequate viability of preserved sections of small intestine.

  • Open Access

    ETIOPATHOGENESIS AND SURGICAL TREATMENT OF BILIARY PANCREATITIS. REVIEW

    by Aimagambetov M.ZH., Masalov A.E., Lubyansky V.G., Omarov N.B., Abdrakhmanov S.T., Auyenov M.A., Zhussupov S.M., Bokin D.S.

    Introduction: Biliary pancreatitis is one of the most common pathologies, which is an important problem of modern surgery and has been on the rise over the past decades. One of the main etiological factors in the development of pancreatitis are diseases of the extrahepatic biliary tract. Pancreatitis of biliary genesis accounts for 26% to 60% of cases of acute inflammation of the pancreas. Chronicization of acute biliary pancreatitis reaches 43% of cases. The leading factors in the pathogenesis of "biliary" pancreatitis are: violation of outflow through the extrahepatic biliary tract and the ductal system of the pancreas, the occurrence of biliary-pancreatic reflux with the development of intraductal hypertension. Unfavorable outcomes of acute pancreatitis do not tend to decrease and are observed in 30% of the number of hospitalized patients, in 80% of which, according to pathological anatomical autopsies, death is due to a severe form of the disease. The main peaks of mortality in acute pancreatitis occur in two main phases - early, most often associated with the phenomena of pancreatogenic shock, and late, due to infectious complications of destructive forms. Purulent complications of acute pancreatitis are so diverse in form and localization that they require an almost individual approach to the treatment of each individual patient. Objective: To review the literature on the surgical treatment of biliary pancreatitis. Research methods: Literature search was carried out in search engines: Pubmed, Google Academy, elibrary.ru, as well as "manually". The search depth of Pubmed, Google Academy, elibrary.ru, as well as "manually", was not limited. The following filters were applied: full text, humans. Criteria for inclusion of publications in the review: publications that are in full-text access, in Russian and English, carrying statistically verified conclusions. Exclusion criteria: duplicate data, summaries of reports, newspaper publications, personal communications. Results: Unfavorable outcomes of acute pancreatitis do not tend to decrease and are observed in 30% of the number of hospitalized patients, in 80% of which the fatal outcome according to pathological anatomical autopsies is due to a severe form of the disease. The main peaks of mortality in acute pancreatitis occur in two main phases - early, most often associated with the phenomena of pancreatogenic shock, and late, due to infectious complications of destructive forms. Purulent complications of acute pancreatitis are so diverse in form and localization that they require an almost individual approach to the treatment of each individual patient. Discussed and insufficiently unambiguous at the present time remains surgical tactics for various forms of acute pancreatitis in etiology. Conclusions: Thus, high prevalence rates, frequent complications of biliary pancreatitis, the presence of numerous risk factors for its development necessitate the search for the most optimal methods for timely diagnosis and surgical treatment of this disease. Введение: Билиарный панкреатит является одной из наиболее распространенных патологий, представляющей собой важную проблему современной хирургии и имеет тенденцию к росту в течение последних десятилетий. Одним из основных этиологических факторов в развитии панкреатита являются заболевания внепеченочных желчных путей. На долю панкреатита билиарного генеза приходится от 26% до 60% наблюдений острого воспаления поджелудочной железы. Хронизация острого билиарного панкреатита достигает 43% случаев. Ведущими факторами патогенеза «билиарного» панкреатита служат: нарушение оттока по внепеченочным желчным путям и протоковой системе поджелудочной железы, возникновение билиарно-панкреатического рефлюкса с развитием внутрипротоковой гипертензии. Неблагоприятные исходы ОП не имеют тенденции к снижению и наблюдаются у 30% от числа госпитализированных больных, в 80% из которых летальный исход по данным патологоанатомических вскрытий обусловлен тяжелой формой заболевания. Основные пики летальности при ОП приходятся на две основные фазы – раньнюю, чаще всего связанную с явлениями панкреатогенного шока, и позднюю, обусловленную инфекционными осложнниями деструктивных форм. Гнойные осложнения ОП настолько разнообразны по форме и локализации, что требуют практически индивидуального подхода к лечению каждого конкретного пациента. Цель: Провести обзор литературы по хируггическому лечению билиарного панкреатита. Методы исследования: Поиск литературы осуществлен в поисковых системах: Pubmed, Google Академия, elibrary.ru, а также «ручным способом». Глубина поиска Pubmed, Google Академия, elibrary.ru, а также...

  • Evaluation and surgical correction of intra-abdominal hypertension in patients with postoperative peritonitis

    by A.N. Zharikov, V.G. Lubyansky, A.R. Aliev

    Оценка и хирургическая коррекция внутрибрюшной гипертензии у больных с послеоперационным перитонитом